DIN 02143305 — VINCRISTINE SULFATE INJECTION 1 MG
VINCRISTINE SULFATE INJECTION is a solution of Vincristine marketed by TEVA CANADA LIMITED. The full Vincristine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02143305
- Brand name
- VINCRISTINE SULFATE INJECTION
- Active ingredient
- Vincristine
- Strength
- 1 MG
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Manufacturer
- TEVA CANADA LIMITED
- Health Canada status
- MARKETED
- Drug class
- Vinca alkaloid antineoplastic agent
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Vincristine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02183013 | VINCRISTINE SULFATE INJECTION USP | 1 MG | SOLUTION | PFIZER CANADA ULC | MARKETED |